Varda Space Industries completes May 18 reentry mission as CEO maps space-based medicine path to manufacturing
Varda Space Industries says it completed its latest reentry mission on May 18, continuing to back both pharmaceutical research payload work and hypersonic testing. In a fireside chat at ASCEND, CEO Bruey outlined a strategy to move space-based medicine from “research novelty” toward manufacturing at scale.